A Phase II Study of Maintenance With Azacitidine in MDS Patients

NCT00446303 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes

Interventions

DRUG: Azacitidine

Sponsor

Groupe Francophone des Myelodysplasies

Collaborators

[object Object]